Cosimo Martino

2.2k total citations
18 papers, 212 citations indexed

About

Cosimo Martino is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Cosimo Martino has authored 18 papers receiving a total of 212 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 10 papers in Pulmonary and Respiratory Medicine and 5 papers in Cancer Research. Recurrent topics in Cosimo Martino's work include Colorectal Cancer Treatments and Studies (14 papers), HER2/EGFR in Cancer Research (8 papers) and Gastric Cancer Management and Outcomes (8 papers). Cosimo Martino is often cited by papers focused on Colorectal Cancer Treatments and Studies (14 papers), HER2/EGFR in Cancer Research (8 papers) and Gastric Cancer Management and Outcomes (8 papers). Cosimo Martino collaborates with scholars based in Italy, United States and Belgium. Cosimo Martino's co-authors include Silvia Marsoni, Andrea Sartore‐Bianchi, Salvatore Siena, Sara Lonardi, Alberto Bardelli, Vittorina Zagonel, Fortunato Ciardiello, Francesco Leone, Alessio Amatu and Livio Trusolino and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and The FASEB Journal.

In The Last Decade

Cosimo Martino

18 papers receiving 208 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cosimo Martino Italy 10 151 83 54 50 49 18 212
Ignacio Tusquets Spain 9 131 0.9× 110 1.3× 50 0.9× 59 1.2× 19 0.4× 16 252
Riham Katkhuda United States 6 150 1.0× 65 0.8× 42 0.8× 41 0.8× 68 1.4× 15 197
Santosh Gupta United States 6 122 0.8× 163 2.0× 73 1.4× 106 2.1× 30 0.6× 15 246
Giovanni Burrafato Italy 9 157 1.0× 139 1.7× 64 1.2× 96 1.9× 35 0.7× 13 247
Shuqiong Fan China 7 88 0.6× 91 1.1× 102 1.9× 57 1.1× 25 0.5× 10 204
Krassimir Koynov Bulgaria 6 195 1.3× 114 1.4× 47 0.9× 35 0.7× 15 0.3× 12 242
Sofie Palmans Belgium 5 250 1.7× 53 0.6× 62 1.1× 71 1.4× 118 2.4× 9 325
Leonie K. de Klerk Netherlands 4 119 0.8× 87 1.0× 59 1.1× 41 0.8× 22 0.4× 4 219
Zhao-Li Tan China 7 127 0.8× 42 0.5× 61 1.1× 69 1.4× 35 0.7× 17 186
S. Kappel Austria 4 234 1.5× 61 0.7× 88 1.6× 136 2.7× 36 0.7× 9 297

Countries citing papers authored by Cosimo Martino

Since Specialization
Citations

This map shows the geographic impact of Cosimo Martino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cosimo Martino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cosimo Martino more than expected).

Fields of papers citing papers by Cosimo Martino

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cosimo Martino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cosimo Martino. The network helps show where Cosimo Martino may publish in the future.

Co-authorship network of co-authors of Cosimo Martino

This figure shows the co-authorship network connecting the top 25 collaborators of Cosimo Martino. A scholar is included among the top collaborators of Cosimo Martino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cosimo Martino. Cosimo Martino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Sartore‐Bianchi, Andrea, Federica Tosi, Francesca Bergamo, et al.. (2020). 507P Central nervous system recurrence in HER2-positive metastatic colorectal cancer. Annals of Oncology. 31. S455–S455. 2 indexed citations
2.
Sartore‐Bianchi, Andrea, Sara Lonardi, Massimo Aglietta, et al.. (2020). Central Nervous System as Possible Site of Relapse in ERBB2-Positive Metastatic Colorectal Cancer. JAMA Oncology. 6(6). 927–927. 24 indexed citations
3.
Giannini, Valentina, Simone Mazzetti, Arianna Defeudis, et al.. (2019). Radiomics features on CT scans to predict response to HER2-targeted therapy of hepatic metastases from colorectal cancer.. Journal of Clinical Oncology. 37(15_suppl). e15086–e15086. 1 indexed citations
4.
5.
Bardelli, Alberto, Giulia Siravegna, Andrea Sartore‐Bianchi, et al.. (2018). Plasma HER2 (ERBB2) copy number to predict response to HER2-targeted therapy in metastatic colorectal cancer.. Journal of Clinical Oncology. 36(15_suppl). 3506–3506. 8 indexed citations
6.
Sartore‐Bianchi, Andrea, Alessio Amatu, Luca Porcu, et al.. (2018). Clinicopathological characteristics and HER2 status in metastatic colorectal cancer patients: Results of a diagnostic model development study.. Journal of Clinical Oncology. 36(4_suppl). 581–581. 3 indexed citations
7.
Siena, Salvatore, Andrea Sartore‐Bianchi, Livio Trusolino, et al.. (2017). Abstract CT005: Final results of the HERACLES trial in HER2-amplified colorectal cancer. Cancer Research. 77(13_Supplement). CT005–CT005. 18 indexed citations
8.
Siena, Salvatore, Andrea Sartore‐Bianchi, Livio Trusolino, et al.. (2016). Final Results of the HERACLES trial in HER2 amplified colorectal cancer. Annals of Oncology. 27. iv39–iv39. 12 indexed citations
9.
Sartore‐Bianchi, Andrea, Silvia Marsoni, Livio Trusolino, et al.. (2016). Pertuzumab and trastuzumab-emtansine in HER2 positive metastatic colorectal cancer: the HERACLES B TRIAL. Annals of Oncology. 27. iv47–iv47. 1 indexed citations
10.
Siena, Salvatore, Alberto Bardelli, Andrea Sartore‐Bianchi, et al.. (2016). HER2 amplification as a ‘molecular bait’ for trastuzumab-emtansine (T-DM1) precision chemotherapy to overcome anti-HER2 resistance in HER2 positive metastatic colorectal cancer: The HERACLES-RESCUE trial.. Journal of Clinical Oncology. 34(4_suppl). TPS774–TPS774. 18 indexed citations
11.
Trusolino, Livio, Andrea Bertotti, Sara Lonardi, et al.. (2016). Abstract CT082: Pertuzumab and trastuzumab-emtansine in HER2-positive colorectal cancer: the HERACLES B trial. Cancer Research. 76(14_Supplement). CT082–CT082. 3 indexed citations
12.
Siena, Salvatore, Andrea Sartore‐Bianchi, Sara Lonardi, et al.. (2015). Trastuzumab and lapatinib in HER2-amplified metastatic colorectal cancer patients (mCRC): The HERACLES trial.. Journal of Clinical Oncology. 33(15_suppl). 3508–3508. 34 indexed citations
13.
Siena, Salvatore, Andrea Sartore‐Bianchi, Livio Trusolino, et al.. (2015). Therapeutic dual inhibition of HER2 pathway for metastatic colorectal cancer (mCRC): The HERACLES trial.. Journal of Clinical Oncology. 33(3_suppl). 565–565. 11 indexed citations
14.
Marsoni, Silvia, Andrea Bertotti, Andrea Sartore‐Bianchi, et al.. (2013). Dual anti-HER2 treatment of patients with HER2-positive metastatic colorectal cancer: The HERACLES trial (HER2 Amplification for Colo-rectaL Cancer Enhanced Stratification).. Journal of Clinical Oncology. 31(15_suppl). TPS3648–TPS3648. 10 indexed citations
15.
Lorenzato, Annalisa, Cosimo Martino, Nadia Dani, et al.. (2012). The cellular apoptosis susceptibility CAS/CSE1L gene protects ovarian cancer cells from death by suppressing RASSF1C. The FASEB Journal. 26(6). 2446–2456. 28 indexed citations
16.
Fuso, Luca, Roberto Passera, Annamaria Ferrero, et al.. (2012). Daily administration of low molecular weight heparin increases Hepatocyte Growth Factor serum levels in gynaecological patients: pharmacokinetic parameters and clinical implications. BMC Research Notes. 5(1). 517–517. 3 indexed citations
17.
Costa, Barbara, Daniela Dettori, Annalisa Lorenzato, et al.. (2010). Fumarase tumor suppressor gene and MET oncogene cooperate in upholding transformation and tumorigenesis. The FASEB Journal. 24(8). 2680–2688. 13 indexed citations
18.
Soloway, Mark S., et al.. (1978). Immunogenicity of N-[-4-(5-nitro-2-furyl)-2-thiazolyl]formamide-induced bladder cancer.. PubMed. 293–300. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ignacio Tusquets Breakdown of academic impact, for papers by Riham Katkhuda Breakdown of academic impact, for papers by Santosh Gupta Breakdown of academic impact, for papers by Giovanni Burrafato Breakdown of academic impact, for papers by Shuqiong Fan Breakdown of academic impact, for papers by Krassimir Koynov Breakdown of academic impact, for papers by Sofie Palmans Breakdown of academic impact, for papers by Leonie K. de Klerk Breakdown of academic impact, for papers by Zhao-Li Tan Breakdown of academic impact, for papers by S. Kappel
Rankless by CCL
2026